U of M signs license deal for new organ technology
Go Deeper.
Create an account or log in to save stories.
Like this?
Thanks for liking this story! We have added it to a list of your favorite stories.
The University of Minnesota has signed a license agreement to form a start-up company to market organ-replacement technology developed by a university scientist.
The university says it recently signed an exclusive, global license deal with Miromatrix Medical Inc. to commercialize the work of Dr. Doris Taylor.
In 2008, Taylor's team got national attention when it announced that it had stripped a rat heart of its cells then repopulated the leftover cellular scaffolding and restarted the heart.
The university says the technology licensed to Miromatrix could one day result in scientists growing replacement organs for patients in a laboratory.
Under the agreement, the university will get equity in the new company as well as future royalty and sublicensing fees.
(Copyright 2010 by The Associated Press. All Rights Reserved.)
Turn Up Your Support
MPR News helps you turn down the noise and build shared understanding. Turn up your support for this public resource and keep trusted journalism accessible to all.
Dear reader,
Your voice matters. And we want to hear it.
Will you help shape the future of Minnesota Public Radio by taking our short Listener Survey?
It only takes a few minutes, and your input helps us serve you better—whether it’s news, culture, or the conversations that matter most to Minnesotans.
